Skip to main content Skip to main navigation
Government logo | to homepage of National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • Nederlands
  • English
  • Home
  • News

News


Search

Fill in your search phrase.

Topics

  • (-) Immunisation and vaccination (3)
  • (-) National Immunisation Programme (2)
  • (-) Flu and flu vaccine (1)
  • (-) Nitrogen (1)
  • (-) Tobacco (1)
  • International (7)
  • COVID-19 (2)
  • COVID-19 vaccination (2)
  • Healthy living environment (1)
  • International projects (1)
  • One Health (1)
  • Perinatal screening (1)
  • PFAS (1)
  • Zoonotic diseases (1)

Publication date

  • September 2021 (2)
  • December 2019 (4)

Vaccination coverage increases for second consecutive year, by 10% for HPV

The percentage of children receiving vaccinations from the National Immunisation Programme rose again last year. Another striking note is the 10% increase in HPV vaccination, rising to 63%.
30-09-2021 | 11:25
Het aantal jonge vrouwen dat zich laat vaccineren tegen HPV is toegenomen met 10%

Flu jab for additional groups

The flu jab is offered free of charge every year to people aged 60 years and older, and to people who are at higher risk of becoming seriously ill from the flu virus due to medical reasons
22-09-2021 | 11:00

Interim injunction decision Nitrogen

In an interim injunction proceeding between Mesdag Zuivelfonds, Stichting Stikstofclaim and RIVM, the court has ruled that RIVM must decide on the availability and disclosure of data before 1 Janua

17-12-2019 | 14:55

A pregnant woman can protect her baby against whooping cough with 22-week vaccination

From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.

12-12-2019 | 11:00

How to distinguish a dual user from an exclusive e-cigarette user

RIVM and Maastricht University have identified a combination of factors that can be used to distinguish between exclusive e-cigarette users (vapers) on the one hand and people who smoke both regula

10-12-2019 | 16:26
e-sigaret

Report on the developments of the National Immunisation Programme: stabilisation of participation and low level of disease

In the first six months of 2019, the number of notified meningococcal serogroup W (MenW) disease cases decreased in almost all age groups, after a continuous increase since 2015.

05-12-2019 | 08:53

Share this page


  • Facebook
  • Twitter
  • LinkedIn
  • WhatsApp
  • Email

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Copyright
  • Responsible disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS reed
  • Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon